Table 2.
Month | 0 | 6 | 12* | ||
Time of assessment | t0 | t1 | t2 | ||
Primary outcome | |||||
Depression (PHQ-9) | X | X | X | ||
Secondary outcomes | |||||
Sociodemographic data | X | partial | partial | ||
Comorbidity (CDI, modified**) | X | – | X | ||
Anxiety (GAD-7) | X | X | X | ||
Pain (CPG, modified**) | X | X | X | ||
Resource utilization (FIMA) | X | X | X | ||
Preference-based quality of life (EQ-5D) | X | X | X | ||
Resilience (RS-13) | X | X | X | ||
Depression-related behavior (Ludman et al. [44], modified**) | X | X | X | ||
Problem-solving skills | X | X | X | ||
Current life situation | X | X | X | ||
Intervention group only | |||||
Evaluation of intervention | – | – | X | ||
Therapy preference questionnaire | X | – | – | ||
Depression (PHQ-9) - additional measures | – | each session | – | each session | – |
*Primary time of assessment (t2) after intervention.
**Linguistic and culture-specific modifications
Abbreviations: PHQ-9, the Patient Health Questionnaire; CDI, the Comorbidity Disease Index; GAD-7, the seven-item Generalized Anxiety Disorder Scale; CPG, the Graded Chronic Pain Scale; FIMA, Fragebogen zur Inanspruchnahme medizinischer und nicht-medizinischer Versorgungsleistungen im Alter; EQ-5D, EuroQol Group; RS-13, the 13-item Resilience Scale.